Calendar CureVac N.V.

Equities

CVAC

NL0015436031

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-05-15 pm EDT			5-day change	1st Jan Change
3.425 ^USD	+1.63%		-4.60%	+0.44%

Apr. 30	UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating	MT
Apr. 11	CUREVAC : 2025 will be less costly

Chart calendar CureVac N.V.

52.QQiBVl9EhtMMeCZ87SVaoijbzhV8WQss8zPFSiVB0GM.BzjRYhEb0utgIE8_lVAY8gW2gEIIECZhpEWVAHcCuC8gXcMVCHbBkkogfw~50c424ecaa8ccc99ce4898f602e1d1ba

Upcoming events on CureVac N.V.

2025-05-20	Q1 2025 Earnings Release (Projected)
2025-08-13	Q2 2025 Earnings Release (Projected)
2025-11-17	Q3 2025 Earnings Release (Projected)
2026-04-28	Q4 2025 Earnings Release (Projected)

Past events on CureVac N.V.

2025-04-10 09:00 am	Q4 2024 Earnings Call
2025-04-10 07:12 am	Q4 2024 Earnings Release
2025-04-01	Van Lanschot Kempen Life Sciences Conference
2025-03-26	Goldman Sachs Biopharma Innovation Summit
2025-03-10 10:40 am	Leerink Partners Global Healthcare Conference
2024-11-14 01:44 pm	International mRNA Health Conference
2024-11-14 09:38 am	International mRNA Health Conference
2024-11-13 01:00 pm	Guggenheim Securities Healthcare Innovation Conference
2024-11-12 09:00 am	Q3 2024 Earnings Call
2024-11-12 07:00 am	Q3 2024 Earnings Release
2024-11-08	Society for Immunotherapy of Cancer Meeting - Abstract No:380
2024-11-08	Society for Immunotherapy of Cancer Meeting - Abstract No:370
2024-11-07	Society for Immunotherapy of Cancer Meeting - Abstract No:697
2024-09-15 03:00 am	European Society for Medical Oncology Meeting - Abstract No: 22P
2024-09-13 08:00 am	European Society for Medical Oncology Meeting - Abstract No: 440O
2024-08-15 07:06 am	Q2 2024 Earnings Release
2024-06-24 08:00 am	Annual General Meeting
2024-06-11	Goldman Sachs Global Healthcare Conference
2024-06-05 07:30 am	Jefferies Global Healthcare Conference
2024-05-23 07:00 am	Q1 2024 Earnings Release

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million EUR	Released Forecast Spread	67,4 73,4 -8.19%	53,8 66,3 -18.8%	535 524 2.1%	70,1	99,9	165
EBITDA Million EUR	Released Forecast Spread	-226 -190 -19.04%	-251 -185 -35.3%	196 218 -9.68%	-91,7	-91,9	-39,8
EBIT Million EUR	Released Forecast Spread	-249 -196 -27.26%	-274 -210 -30.42%	178 192 -7.54%	-90,5	-91,9	-10,4
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-249 -205 -21.25%	-260 -186 -39.71%	190 197 -3.38%	-78,7	-98,9	-35,8
Net income Million EUR	Released Forecast Spread	-249 -199 -24.98%	-260 -199 -30.71%	162 176 -8.02%	-104	-95,3	-35,8
EPS EUR	Released Forecast Spread	-1,32 -1,04 -26.45%	-1,18 -0,95 -24.78%	0,72 0,57 26.29%	-0,46	-0,42	-0,16
Announcement Date		25/04/23	24/04/24	10/04/25	-

Quarterly results

Fiscal Period	December	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales Million EUR	Released Forecast Spread	7,58 13,7 -44.88%	16,5 16,0 3.27%	22,6 29,1 -22.29%	12,4 12,9 -4%	14,4 4,91 193.94%	494 138 257.05%	14,5 20,6 -29.55%	3,34	34,6	3,34	29,6
EBIT Million EUR	Released Forecast Spread	-71,8 -55,6 -29.12%	-54,0 -52,2 -3.5%	-88,0 -36,0 -144.59%	-73,3 -57,4 -27.72%	-73,6 -58,2 -26.6%	368 341 7.9%	-43,8 5,99 -830.91%	-47,3	18,8	-41,2	13,2
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-67,4 -47,0 -43.38%	-48,7 -52,0 6.35%	-86,5 -28,0 -208.93%	-69,9 -55,0 -27.07%	-71,2	371 128 188.54%	-38,6 24,2 -259.25%	-45,5	20,3	-39,4	14,9
Net income Million EUR	Released Forecast Spread	-67,4 -43,4 -55.33%	-48,7 -37,3 -30.51%	-86,7 -25,3 -242.5%	-70,6 -48,8 -44.72%	-72,5 -53,0 -36.87%	338 328 3.11%	-32,8 6,86 -577.62%	-41,1	2,44	-37,7	-2,43
EPS EUR	Released Forecast Spread	-0,30 -0,22 -34.51%	-0,22 -0,24 7.9%	-0,39 -0,18 -112.38%	-0,31 -0,24 -29.16%	-0,32 -0,30 -6.26%	1,50 0,42 254.72%	-0,14 -0,19 26.55%	-0,18	0,01	-0,17	-0,01
Announcement Date		17/08/23	14/11/23	24/04/24	23/05/24	15/08/24	12/11/24	10/04/25	-	-	-	-

Upcoming sector events for CureVac N.V.

2025-05-20	CUREVAC N.V.: Q1 2025 Earnings Release (Projected)
2025-05-20	EXSCIENTIA PLC: Q1 2025 Earnings Release (Projected)
2025-05-21 02:00 am	BIOARCTIC AB: Q1 2025 Earnings Release
2025-05-27	MESOBLAST LIMITED: Q3 2025 Earnings Release (Projected)
2025-05-27	IMMUNOVANT, INC.: Q4 2025 Earnings Release (Projected)
2025-07-22	ALKERMES PLC: Q2 2025 Earnings Release (Projected)
2025-07-22	ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release (Projected)
2025-07-22	SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-22	LONZA GROUP AG: Q2 2025 Earnings Release
2025-07-23 04:01 pm	GALAPAGOS NV: Q2 2025 Earnings Release

More events

Past sector events for CureVac N.V.

2025-05-14	REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release (Projected)
2025-05-14	GNI GROUP LTD.: Q1 2025 Earnings Release
2025-05-14 07:30 am	ARBUTUS BIOPHARMA CORPORATION: Q1 2025 Earnings Release
2025-05-14 07:00 am	CENTESSA PHARMACEUTICALS PLC: Q1 2025 Earnings Release
2025-05-14 07:00 am	ARS PHARMACEUTICALS, INC.: Q1 2025 Earnings Release
2025-05-13 04:05 pm	PHARVARIS N.V.: Q1 2025 Earnings Release
2025-05-13 04:01 pm	GRAIL, INC.: Q1 2025 Earnings Release
2025-05-13 08:00 am	CG ONCOLOGY, INC.: Q1 2025 Earnings Release
2025-05-12	TAKARA BIO INC.: Q4 2025 Earnings Release
2025-05-12 04:05 pm	BIOHAVEN LTD.: Q1 2025 Earnings Release